Robust Alpha Spending for Unstable Data
Statistics in Medicine · 2026
DOI: 10.1002/sim.70760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2026. Verfasst von Ivair R Silva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Robert H. Ebert Career Development Award.
Abstract (Originalsprache)
Sequential hypothesis testing has been used in randomized clinical trials and in monitoring adverse events after vaccination. Typically, the presumption is that all data that have been previously used in the sequential analysis remain the same, and only new data are added. We call this the “anchoring” assumption. In prelicensing randomized trials, enrollment goals are set based on these sequential hypothesis tests so that a trial may stop if a drug proves either too hazardous or, conversely, so beneficial that it would be unethical to deny the treatment to others. However, in monitoring adverse events after vaccination, data are mostly “secondary use,” or real‐world data. That is, these data are not gathered for research, but are clinical data that have been repurposed for observational vaccine safety surveillance. As such, the counts of exposed persons and adverse events may be subject to revisions over time. These data changes directly challenge the anchoring assumption upon which most sequential hypothesis testing depends. If these data changes are discovered prior to subsequent hypothesis tests, it is unclear how to account for these changes in subsequent tests. We introduce a solution: “robust alpha spending” to protect overall type I error probability, statistical power, and surveillance time from low‐level data instability present in secondary use data sources used for adverse event monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
- Computer Department, Federal University of Ouro Preto, Ouro Preto, Brazil.
- Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Ivair R Silva, Judith C Maro
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Robert H. Ebert Career Development Award
Zitieren
APA
Silva, I. R., & Maro, J. C. (2026). Robust Alpha Spending for Unstable Data. Statistics in Medicine. https://doi.org/10.1002/sim.70760
Vancouver
Silva IR, Maro JC. Robust Alpha Spending for Unstable Data. Statistics in Medicine. 2026. doi:10.1002/sim.70760
BibTeX
@article{Silva2026,
author = {Silva, Ivair R and Maro, Judith C},
title = {Robust Alpha Spending for Unstable Data},
journal = {Statistics in Medicine},
year = {2026},
doi = {10.1002/sim.70760}
}
EUVIMED